Helios Cardio

Helios Cardio

MA - Weston
Biotechnology

Focus: Development of regenerative biologic matrices

Helios Cardio is a life sciences company focused on Development of regenerative biologic matrices.

OncologyCardiovascular
Funding Stage
PUBLIC
Open Jobs
3

Pipeline & Clinical Trials

CardiaMend in Combination with Amiodarone
Atrial Fibrillation
Phase 1
Clinical Trials (1)
NCT06063538Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone
Phase 1
The intervention includes Amiodarone-Infused CardiaMend patches
Atrial Fibrillation, Postoperative
Phase 1/2
Clinical Trials (1)
NCT06730828Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
Phase 1/2
CardiaMend with the Addition of Amiodarone
Post Operative Atrial Fibrillation
Phase 4
Clinical Trials (1)
NCT05681182Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone
Phase 4

Open Jobs (3)

Interview Prep Quick Facts
Portfolio: 3 clinical trials
Open Roles: 3 active jobs